Narra S. Devi

6.8k total citations
20 papers, 1.1k citations indexed

About

Narra S. Devi is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Narra S. Devi has authored 20 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 12 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Narra S. Devi's work include Cancer, Hypoxia, and Metabolism (12 papers), ATP Synthase and ATPases Research (3 papers) and Glioma Diagnosis and Treatment (3 papers). Narra S. Devi is often cited by papers focused on Cancer, Hypoxia, and Metabolism (12 papers), ATP Synthase and ATPases Research (3 papers) and Glioma Diagnosis and Treatment (3 papers). Narra S. Devi collaborates with scholars based in United States, China and Poland. Narra S. Devi's co-authors include Erwin G. Van Meir, Daniel J. Brat, Mourad Tighiouart, Balveen Kaur, Kenneth L. Friedrich, Keith D. Wilkinson, Karen Ventii, Tatiana A. Chernova, Zhaobin Zhang and Štefan Kaluz and has published in prestigious journals such as Cancer Cell, Cancer Research and Oncogene.

In The Last Decade

Narra S. Devi

19 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Narra S. Devi United States 16 710 325 266 172 153 20 1.1k
Micaela Quarto Italy 16 1.5k 2.2× 318 1.0× 773 2.9× 100 0.6× 204 1.3× 18 1.9k
Marcus Bosenberg United States 13 801 1.1× 322 1.0× 384 1.4× 77 0.4× 188 1.2× 20 1.2k
Graeme J. Walker Australia 23 1.4k 2.0× 585 1.8× 1.3k 5.0× 232 1.3× 332 2.2× 66 2.3k
Meghna Das Thakur United States 14 820 1.2× 260 0.8× 580 2.2× 54 0.3× 105 0.7× 28 1.3k
Kristy R. Stengel United States 20 952 1.3× 186 0.6× 278 1.0× 106 0.6× 286 1.9× 42 1.3k
Zhaomei Mu United States 22 577 0.8× 605 1.9× 752 2.8× 84 0.5× 88 0.6× 43 1.3k
Ludmilla de Plater France 13 405 0.6× 249 0.8× 458 1.7× 92 0.5× 79 0.5× 23 934
Joanna Lisztwan Switzerland 12 1.3k 1.8× 758 2.3× 790 3.0× 156 0.9× 287 1.9× 16 1.9k
Christiane Margue Luxembourg 19 1.1k 1.6× 607 1.9× 588 2.2× 74 0.4× 323 2.1× 32 1.7k
Roberta Sommaggio Italy 16 1.1k 1.5× 389 1.2× 619 2.3× 87 0.5× 274 1.8× 34 1.8k

Countries citing papers authored by Narra S. Devi

Since Specialization
Citations

This map shows the geographic impact of Narra S. Devi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Narra S. Devi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Narra S. Devi more than expected).

Fields of papers citing papers by Narra S. Devi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Narra S. Devi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Narra S. Devi. The network helps show where Narra S. Devi may publish in the future.

Co-authorship network of co-authors of Narra S. Devi

This figure shows the co-authorship network connecting the top 25 collaborators of Narra S. Devi. A scholar is included among the top collaborators of Narra S. Devi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Narra S. Devi. Narra S. Devi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kuranaga, Yuki, Bing Yu, Satoru Osuka, et al.. (2024). Targeting Integrin α3 Blocks β1 Maturation, Triggers Endoplasmic Reticulum Stress, and Sensitizes Glioblastoma Cells to TRAIL-Mediated Apoptosis. Cells. 13(9). 753–753. 3 indexed citations
2.
Kaluz, Štefan, Qing Zhang, Yuki Kuranaga, et al.. (2021). Targeting HIF-activated collagen prolyl 4-hydroxylase expression disrupts collagen deposition and blocks primary and metastatic uveal melanoma growth. Oncogene. 40(33). 5182–5191. 24 indexed citations
3.
Yu, Bing, Zhaobin Zhang, Satoru Osuka, et al.. (2020). A Chimeric Signal Peptide–Galectin-3 Conjugate Induces Glycosylation-Dependent Cancer Cell–Specific Apoptosis. Clinical Cancer Research. 26(11). 2711–2724. 8 indexed citations
4.
Zhang, Hanwen, Dan Zhu, Zhaobin Zhang, et al.. (2019). EZH2 targeting reduces medulloblastoma growth through epigenetic reactivation of the BAI1/p53 tumor suppressor pathway. Oncogene. 39(5). 1041–1048. 30 indexed citations
5.
Dong, Lei, Shuo You, Qing Zhang, et al.. (2018). Arylsulfonamide 64B Inhibits Hypoxia/HIF-Induced Expression of c-Met and CXCR4 and Reduces Primary Tumor Growth and Metastasis of Uveal Melanoma. Clinical Cancer Research. 25(7). 2206–2218. 52 indexed citations
6.
Zhu, Dan, Satoru Osuka, Zhaobin Zhang, et al.. (2018). BAI1 Suppresses Medulloblastoma Formation by Protecting p53 from Mdm2-Mediated Degradation. Cancer Cell. 33(6). 1004–1016.e5. 54 indexed citations
7.
Bhattacharya, Debanjan, Dan Zhu, Narra S. Devi, & Erwin G. Van Meir. (2018). Abstract B17: ADGRB3 is a novel tumor suppressor epigenetically silenced in WNT medulloblastoma. Cancer Research. 78(19_Supplement). B17–B17.
8.
Santos, Zeus A. De los, et al.. (2017). Examining the structure-activity relationship of benzopyran-based inhibitors of the hypoxia inducible factor-1 pathway. Bioorganic & Medicinal Chemistry Letters. 27(8). 1731–1736. 8 indexed citations
9.
Kalinina, Juliya, Jun Young Ahn, Narra S. Devi, et al.. (2016). Selective Detection of the D-enantiomer of 2-Hydroxyglutarate in the CSF of Glioma Patients with Mutated Isocitrate Dehydrogenase. Clinical Cancer Research. 22(24). 6256–6265. 52 indexed citations
10.
Yin, Shaoman, Štefan Kaluz, Narra S. Devi, et al.. (2012). Arylsulfonamide KCN1 Inhibits In Vivo Glioma Growth and Interferes with HIF Signaling by Disrupting HIF-1α Interaction with Cofactors p300/CBP. Clinical Cancer Research. 18(24). 6623–6633. 71 indexed citations
11.
Shi, Qi, Shaoman Yin, Štefan Kaluz, et al.. (2012). Binding Model for the Interaction of Anticancer Arylsulfonamides with the p300 Transcription Cofactor. ACS Medicinal Chemistry Letters. 3(8). 620–625. 15 indexed citations
12.
Mun, Ji-Young, Adnan Abdul Jabbar, Narra S. Devi, et al.. (2012). Design and in Vitro Activities of N-Alkyl-N-[(8-R-2,2-dimethyl-2H-chromen-6-yl)methyl]heteroarylsulfonamides, Novel, Small-Molecule Hypoxia Inducible Factor-1 Pathway Inhibitors and Anticancer Agents. Journal of Medicinal Chemistry. 55(15). 6738–6750. 49 indexed citations
13.
14.
Tan, Chalet, Rita G. de Noronha, Narra S. Devi, et al.. (2011). Sulfonamides as a new scaffold for hypoxia inducible factor pathway inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(18). 5528–5532. 30 indexed citations
15.
Mooring, Suazette Reid, Hui Jin, Narra S. Devi, et al.. (2011). Design and Synthesis of Novel Small-Molecule Inhibitors of the Hypoxia Inducible Factor Pathway. Journal of Medicinal Chemistry. 54(24). 8471–8489. 41 indexed citations
16.
Kaur, Balveen, Eric M. Sandberg, Narra S. Devi, et al.. (2009). Vasculostatin Inhibits Intracranial Glioma Growth and Negatively Regulates In vivo Angiogenesis through a CD36-Dependent Mechanism. Cancer Research. 69(3). 1212–1220. 98 indexed citations
17.
Ventii, Karen, Narra S. Devi, Kenneth L. Friedrich, et al.. (2008). BRCA1-Associated Protein-1 Is a Tumor Suppressor that Requires Deubiquitinating Activity and Nuclear Localization. Cancer Research. 68(17). 6953–6962. 258 indexed citations
18.
Post, Dawn E., Eric M. Sandberg, Michele Kyle, et al.. (2007). Targeted Cancer Gene Therapy Using a Hypoxia Inducible Factor–Dependent Oncolytic Adenovirus Armed with Interleukin-4. Cancer Research. 67(14). 6872–6881. 90 indexed citations
19.
Kaur, Balveen, Daniel J. Brat, Narra S. Devi, & Erwin G. Van Meir. (2005). Vasculostatin, a proteolytic fragment of Brain Angiogenesis Inhibitor 1, is an antiangiogenic and antitumorigenic factor. Oncogene. 24(22). 3632–3642. 139 indexed citations
20.
Post, Dawn E., Narra S. Devi, Zhenchao Li, et al.. (2004). Cancer Therapy with a Replicating Oncolytic Adenovirus Targeting the Hypoxic Microenvironment of Tumors. Clinical Cancer Research. 10(24). 8603–8612. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Micaela Quarto Breakdown of academic impact, for papers by Marcus Bosenberg Breakdown of academic impact, for papers by Graeme J. Walker Breakdown of academic impact, for papers by Meghna Das Thakur Breakdown of academic impact, for papers by Kristy R. Stengel Breakdown of academic impact, for papers by Zhaomei Mu Breakdown of academic impact, for papers by Ludmilla de Plater Breakdown of academic impact, for papers by Joanna Lisztwan Breakdown of academic impact, for papers by Christiane Margue Breakdown of academic impact, for papers by Roberta Sommaggio
Rankless by CCL
2026